Plus   Neg

Stock To Watch - General Mills

Shares of food company General Mills, Inc. (GIS) closed Tuesday's trading at $53.56, close to its 52-week high of $56.40.

General Mills' brands include Nature Valley, Betty Crocker, Annie's organic snacks, Häagen-Dazs, Cheerios, and Pillsbury among others.

In November last year, the company achieved its 20% sodium reduction goal across all 10 key U.S. product categories, that was announced in 2010.

Last month, the Fortune 100 multinational company reported better- than- expected adjusted earnings of $0.95 per share in the second quarter. This was a 67% increase from the same quarter a year ago. The Consensus estimate stood at $0.88 per share. Revenue for the quarter was flat at $4.4 billion versus last year.

For FY2020, the company expects earnings, on an adjusted basis, to be in the range of $3.31- $3.38 per share. This compares with the Street expectation of $3.38.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Novacyt S.A. said it is seeing unprecedented demand for the novel coronavirus or COVID-19 diagnostic test kit developed by Primerdesign, the company's molecular diagnostics division based in the UK. As of March 27, Primerdesign has sold and received orders for more than 17.8 million pounds of its CE-Mark COVID-19 tests. Novacyt is currently selling its COVID-19 test to more than 80 countries. The U.S. Food and Drug Administration has issued an Emergency Use Authorization to allow anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate donated to the Strategic National Stockpile as possible treatments for coronavirus (COVID-19) patients. This is the first EUA for a drug related to the COVID-19 response. Gilead Sciences Inc. said it is transitioning to "expanded access programs" from "compassionate use" programs for its experimental anti-coronavirus drug, remdesivir. The company noted that the expanded access will allow hospitals or physicians to apply for emergency use of remdesivir for multiple severely ill patients at one time, as they struggle to deal with the COVID-19 or coronavirus pandemic.
Follow RTT